Riskpilot← Back to searchSign inGet full accessTabletten I Härnösand AB
ABActiveOrg 5591540074Rental and operating of own or leased real estate · NACE 6820Est. 20180 employees
Revenue 2025
SEK 396K
+2% vs 2024
EBITDA margin
55.9%
+94% vs 2024
Equity ratio
18.2%
Financial strength
Net profit 2025
SEK 148K
+126% vs 2024
| Revenue | SEK 396K | +2% |
| EBITDA | SEK 221K | +94% |
| Net profit | SEK 148K | +126% |
| Total assets | SEK 3M | +6% |
| Equity | SEK 550K | +37% |
| Employees | 0 | — |
Legal name
Tabletten I Härnösand AB
Org number
5591540074
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
28 mars 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva fastighetsförvaltning samt därmed förenlig verksamhet, uthyrning och förvaltning av egna eller arrenderade bostäder samt fastigheter.
Address
Email
arne@byggforadling.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 228 | 318 | 351 | 388 | 396 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 116 | 157 | 147 | 114 | 221 |
| Depreciation & amort. | −25 | −38 | −38 | −38 | −38 |
| EBIT | 91 | 119 | 109 | 76 | 184 |
| Net financials | — | −0 | 2 | 7 | 3 |
| Profit before tax | 91 | 119 | 111 | 83 | 187 |
| Tax | −19 | −26 | −24 | −17 | −38 |
| Net profit | 72 | 93 | 87 | 66 | 148 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 655 | 2 761 | 2 835 | 2 864 | 3 027 |
| Equity | 156 | 249 | 336 | 402 | 550 |
| Long-term debt | 2 416 | 2 416 | 2 389 | 2 389 | 2 389 |
| Short-term debt | 83 | 96 | 110 | 74 | 88 |
| Total debt | 2 499 | 2 512 | 2 499 | 2 463 | 2 477 |
EBITDA margin
55.9%
This company
15.8%
Market median
+254% vs market
20212025
Equity ratio
18.2%
This company
38.2%
Market median
-52% vs market
20212025
Return on equity
27.0%
This company
18.4%
Market median
+47% vs market
20212025
Net profit margin
37.4%
This company
8.1%
Market median
+362% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
4.50×
This company
0.62×
Market median
-626% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Prefix Holding AB
Tabletten I Härnösand AB Board members of Tabletten I Härnösand AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Peter Olsson | Board of Directors | 0 companies |
| Karl Arne Bystedt | Board of Directors | 0 companies |
| Anna Elisabet Eriksson | Deputy Board Member | 0 companies |
| Ann Ingrid Linnea Olsson | Deputy Board Member | 0 companies |